The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-07
DOI
10.1007/s00262-018-2266-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer
- (2017) Martin Scurr et al. JAMA Oncology
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
- (2016) Takuro Saito et al. NATURE MEDICINE
- Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood
- (2016) Laura F. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
- (2015) Guido Kroemer et al. OncoImmunology
- Tregitope: Immunomodulation Powerhouse
- (2014) Leslie Cousens et al. HUMAN IMMUNOLOGY
- The immune epitope database (IEDB) 3.0
- (2014) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- (2014) Ole Audun Werner Haabeth et al. Frontiers in Immunology
- Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
- (2013) M Scurr et al. Mucosal Immunology
- Escalating Regulation of 5T4-Specific IFN- + CD4+ T Cells Distinguishes Colorectal Cancer Patients from Healthy Controls and Provides a Target for In Vivo Therapy
- (2013) M. Scurr et al. Cancer Immunology Research
- A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma
- (2012) Lisa M. Ebert et al. PLoS One
- MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
- (2012) Mathilde Bobinet et al. PLoS One
- Identification of promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the cancer-testis antigen HCA587
- (2011) Weigang Wen et al. CANCER SCIENCE
- Suppression of tumour-specific CD4+T cells by regulatory T cells is associated with progression of human colorectal cancer
- (2011) Gareth Betts et al. GUT
- A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination
- (2010) Anne Rogel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
- (2010) M. J. P. Welters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆
- (2009) Constanze A. Weber et al. ADVANCED DRUG DELIVERY REVIEWS
- NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction
- (2009) Morten Nielsen et al. BMC BIOINFORMATICS
- Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
- (2009) Andreas Bonertz et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"
- (2008) A. S. De Groot et al. BLOOD
- Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine
- (2008) M. J.P. Welters et al. CLINICAL CANCER RESEARCH
- MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
- (2008) Yann Godet et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now